Australia’s Potentia closes Fund II on $438m
Australian technology-focused private equity firm Potentia Capital has achieved a first and final close of AUD 635m (USD 438m) on its second fund, hitting the hard cap and beating a target of AUD 500m.
Potentia’s first fund was launched in August 2019 and closed on AUD 382m in January last year. The firm, which positions itself as Australia’s only private equity investor exclusively focused on software...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.